Literature DB >> 26601967

Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases.

Nasimudeen R Jabir, Ali Nasir Siddiqui, Chelapram Kandy Firoz, Ghulam Md Ashraf, Syed Kashif Zaidi, Mohd Shahnawaz Khan, Shazi Shakil, Mohammed Nabil Alama, Mohammad Amjad Kamal, Shams Tabrez1.   

Abstract

Despite the significant advances in the medical research and treatment methods, the rate of mortality associated with cardiovascular disease (CVD) is continuously rising and it remains the leading cause of death worldwide. There are several treatment methods for CVD and associated complications that have been considered till now. The current treatment methods cannot produce rapid cure, but could prevent or reduce the progression of this devastating disease. In the current article, we have summarized the use of various pharmacological agents viz. HMG-CoA reductase inhibitors (statins), antihypertensive, thrombolytic and anticoagulation agents that are currently being used for the management of CVD which targets different biochemical or molecular events. Based on our article, more research in this field is advocated which will provide the rapid and effective treatment methods in order to avoid fatal complications associated with CVD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26601967     DOI: 10.2174/1381612822666151125000746

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

2.  Social Determinant Factors and their Relationship with Nutritional Pattern in Cardiovascular Patients after Hospital Discharge.

Authors:  Hassan Nazari; Davoud Vahabzadeh; Saeed Beygh Mohammadi; Leila Zarei; Masoud Ghahramani
Journal:  Maedica (Bucur)       Date:  2016-09

Review 3.  Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.

Authors:  Simone Marcone; Orina Belton; Desmond J Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

4.  Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients.

Authors:  Nasimudeen R Jabir; Chelapram K Firoz; Mohammad A Kamal; Ghazi A Damanhouri; Mohammed Nabil Alama; Anas S Alzahrani; Hussein A Almehdar; Shams Tabrez
Journal:  J Clin Lab Anal       Date:  2016-11-09       Impact factor: 2.352

5.  Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C)).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 7.  Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.

Authors:  Xue Shen; Zhongwen Zhang; Xiaoqian Zhang; Junyu Zhao; Xiaojun Zhou; Qinglei Xu; Hongxia Shang; Jianjun Dong; Lin Liao
Journal:  Lipids Health Dis       Date:  2016-10-12       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.